Mankind Pharma Ltd. NSE: MANKIND | BSE: 543904

Expensive Performer

Download real time

2471.40 -2.70 (-0.11%)

337.6K

NSE+BSE Volume

NSE 29 Aug, 2025 3:31 PM (IST)

Mankind Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Mankind Pharma Ltd. on BSE

Load latest

Mankind Pharma Ltd.

23 Jan 2025

2471.40

-0.11%

Corp. Note

Mankind Pharma Ltd - 543904 - Integrated Filing (Financial)

BSE India

Outcome of Board Meeting held today i.e. January 23, 2025

Mankind Pharma Ltd.

23 Jan 2025

2471.40

-0.11%

Board Meeting

Mankind Pharma Ltd - 543904 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Outcome of Board Meeting held today i.e. January 23, 2025.

Mankind Pharma Ltd.

16 Jan 2025

2471.40

-0.11%

Company Update

Mankind Pharma Ltd - 543904 - Intimation Regarding Redemption Of Commercial Paper

BSE India

Intimation regarding redemption of Commercial Paper

Mankind Pharma Ltd.

15 Jan 2025

2471.40

-0.11%

Company Update

Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Mankind Pharma Ltd.

14 Jan 2025

2471.40

-0.11%

Company Update

Mankind Pharma Ltd - 543904 - Commercial Paper-Quarterly Certificate December 2024

BSE India

Commercial Paper-Quarterly Certificate December 2024

Mankind Pharma Ltd.

14 Jan 2025

2471.40

-0.11%

Company Update

Mankind Pharma Ltd - 543904 - Intimation Of Record Date For Redemption Of Commercial Paper Issued …

BSE India

Intimation of Record Date for redemption of Commercial Paper issued by the Company

Mankind Pharma Ltd.

14 Jan 2025

2471.40

-0.11%

Company Update

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Investor Conference Call for Q3 & 9M FY25 with Senior Management of Mankind Pharma Limited

Mankind Pharma Ltd.

13 Jan 2025

2471.40

-0.11%

Board Meeting

Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended on December 31, 2024.

Mankind Pharma Ltd.

08 Jan 2025

2471.40

-0.11%

Company Update

Mankind Pharma Ltd - 543904 - Announcement Under Regulation 30 Of SEBI LODR

BSE India

The Board of Directors of the Company at its meeting held today i.e. January 8, 2025 has been designated Mr. Prakash Agarwal, President - Strategy as Senior Management Personnel ("SMP") of the Company.

Mankind Pharma Ltd.

08 Jan 2025

2471.40

-0.11%

Company Update

Mankind Pharma Ltd - 543904 - Appointment of Company Secretary and Compliance Officer

BSE India

The Board of Directors of the Company at its meeting held today i.e. 8th January, 2025 has considered, noted and approved the appointment of Mr. Hitesh Kumar Jain (ICSI Membership No. F6241) as Company Secretary and Compliance Officer w.e.f. January 9, 2025.

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >